Your new experience awaits. Try the new design now and help us make it even better

CLINICAL TRIAL article

Front. Neurol.

Sec. Neurorehabilitation

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1504089

Clinical efficacy observation and safety evaluation of acupuncture for intractable facial paralysis: a single-blinded randomized controlled pilot trial

Provisionally accepted
Hongyu  XieHongyu Xie1Yu  XiaYu Xia2Lele  ZhangLele Zhang2Aihong  YuanAihong Yuan1*JUN  YANGJUN YANG1Ling  ChengLing Cheng2Ting  GaoTing Gao3Bo  LiBo Li4Xuwen  YuanXuwen Yuan5Min  YeMin Ye2Wenjing  KanWenjing Kan2Jie  ShiJie Shi1Zhen  LiuZhen Liu1Fei  YuanFei Yuan1Chao  ZhouChao Zhou6Ojun  LiuOjun Liu7
  • 1First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, China
  • 2Anhui University of Chinese Medicine, Hefei, Anhui Province, China
  • 3Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui Province, China
  • 4Shuguang Hospital Anhui Branch Affiliated to Shanghai University of Traditional Chinese Medicine, Hefei, China
  • 5Bozhou Hospital of Traditional ChineseMedicine, Hefei, China
  • 6First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China
  • 7Bozhou Vocational and Technical College, Bozhou, China

The final, formatted version of the article will be published soon.

Introduction: Acupuncture can effectively improve the clinical symptoms of intractable facial paralysis (IFP). However, it is not yet clear whether the use of acupuncture manipulation affects the therapeutic effect. This study aims to conduct a preliminary exploration of the clinical efficacy and safety of acupuncture treatment for IFP using acupuncture manipulation. Methods: A single-center, single-blind, randomized controlled pilot trial was conducted from December 2022 to December 2023, involving 40 IFP participants, divided into the ordinary acupuncture group (OAG, n = 20) and the characteristic acupuncture group (CAG, n = 20). The OAG underwent a standardized acupuncture protocol comprising 3 weekly sessions over a 10-week period. This structured regimen included 3 consecutive treatment cycles (10 sessions/cycle), culminating in 30 total therapeutic interventions. The CAG has performed characteristic acupuncture manipulation on this basis, with the same frequency and duration of treatment as the OAG. Assess the patient's facial recovery status at baseline and after 10, 20, and 30 treatments. Results: After the second treatment course, the difference in the Anzhong Facial Paralysis Precision Scale (Oral Commissure Ptosis Grading Scale) levels between the two groups began to show statistical significance (P < 0.05) ;After the third treatment course, the scores changes in Sunnybrook Facial Grading System (SFGS) scale between the two groups began to show statistical significance (P < 0.05); After the first treatment course, there was statistical significance in the average ratio changes at LI20 (Yingxiang) and ST4 (Dicang) between the two groups (P < 0.05). After the second treatment course, statistical significance in the average ratio changes was observed at GB14 (Yangbai), SI18 (Quanliao), LI20 (Yingxiang), and ST4 (Dicang) between the two groups (P < 0.05). After the third treatment course, statistical significance in the average ratio changes was found at all acupoints between the two groups (P < 0.05). Consequently, the CAG group demonstrated superior therapeutic efficacy compared to the OAG group. Conclusion: Acupuncture has a good therapeutic effect on IFP, and the combination of characteristic acupuncture manipulation has a better therapeutic effect. However, these conclusions require further validation in larger clinical studies. Clinical trial registration: identifier, ChiCTR2200065442. (https://www.chictr.org.cn/).

Keywords: Acupuncture, intractable facial paralysis, Anzhong Facial Paralysis Precision Scale (OralCommissure Ptosis Grading Scale), surface electromyography, randomized controlled pilot trial

Received: 30 Sep 2024; Accepted: 15 Sep 2025.

Copyright: © 2025 Xie, Xia, Zhang, Yuan, YANG, Cheng, Gao, Li, Yuan, Ye, Kan, Shi, Liu, Yuan, Zhou and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Aihong Yuan, yuanah2023@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.